Neonatal thrombosis

Journal of Clinical Pathology

Volumn 53, Issue 6, 2000, Pages 419-423

  Chalmers, E A ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; INCIDENCE; NEWBORN; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA; THROMBOSIS;

ARTERIAL OCCLUSIVE DISEASES; CANADA; CATHETERIZATION, CENTRAL VENOUS; FACTOR V; GERMANY; HUMANS; INCIDENCE; INFANT, NEWBORN; MUTATION; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM; THROMBOPHILIA; ULTRASONOGRAPHY, DOPPLER; VENOUS THROMBOSIS;

EID: 0034122161     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.53.6.419     Document Type: Review

References (30)

1. 1 David M, Andrew M. Venous thromboembolic complications in children. J Pediatr 1993;123:337-46.
2. 2 Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995;96:939-43.
3. 3 Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997;76:F163-7.
4. 4 O'Neill JA, Neblett WW III, Born ML. Management of major thromboembolic complications of umbilical artery catheters. J Pediatr Surg 1981;16:972-8.
5. 5 Roy M, Turner-Gomes S, Gill G, et al. Incidence and diagnosis of neonatal thrombosis associated with umbilical venous catheters. Thromb Haemost 1997;78(suppl):724.
6. 6 de Veber GA, Adams M, Andrew M. Cerebral thromboembolism in neonates: clinical and radiographic features. Thromb Haemost 1997;78(suppl):725.
7. 7 Massicotte P, Adams M, Marzinotto V, et al. Low molecular weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996;128:313-18.
8. 8 Schmidt B, Buchanan M, Ofosu F, et al. Antithrombotic properties of heparin in a neonatal piglet model of thrombin induced thrombosis. Thromb Haemost 1988;60: 289-92.
9. 9 Andrew M, Michelson AD, Bovill E, et al. Guidelines for antithrombotic therapy in pediatric patients. J Pediatr 1998;132:575-88.
10. 10 Chalmers EA, Gibson BES. Thrombolytic therapy in children. Br J Haematol 1999;104:14-21.
11. 11 Leaker M, Massicotte MP, Brooker LA, et al. Thrombolytic therapy in paediatric patients: a comprehensive review of the literature. Thromb Haemost 1996;76:132-4.
12. 12 Zenz W, Arlt F, Sodia S, et al. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years. Semin Thromb Hemost 1997;23:321-32.
13. 13 Andrew M, Paes B, Milner R, et al. Development of the coagulation system in the full-term infant. Blood 1987;70: 165-72.
14. 14 Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104.
15. 15 Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;80:1998-2005.
16. 16 Sanchez J, Velasco F, Alvarez R, et al. Aortic thrombosis in a neonate with hereditary antithrombin III deficiency: successful outcome with thrombolytic and replacement therapy. Acta Paediatr 1996;85:245-47.
17. 17 Kodish E, Potter C, Kirschbaum NE, et al. Activated protein C resistance in a neonate with venous thrombosis. J Pediatr 1995;127:645-8.
18. 18 Aschka I, Aumann V, Bergmann F, et al. Prevalence of the factor V Leiden mutation in children with thromboembolism. Eur J Pediatr 1996;155:1009-14.
19. 19 Nowak-Gottl U, Dubbers A, Kececioglu D, et al. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 1997;131:608-12.
20. 20 Manc-Johnson M, Sifontes M, Nuss R, et al. Coagulation abnormalities in neonatal catheter related thromboses. Thromb Haemost 1999;82(suppl):384.
21. 21 Hagstrom JN, Walter J, Bluebond-Langner R, et al. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998;133: 777-81.
22. 22 Zenz W, Bodo Z, Plotho J, et al. Factor V Leiden and prothrombin gene 20210 A varient in children with ischaemic stroke. Thromb Haemost 1998;80:763-6.
23. 23 Manco-Johnson MJ, Abshire TC, Jacobson LJ, et al. Severe neonatal protein C deficiency: prevalence and thrombotic risk. J Pediatr 1991;119:793-8.
24. 24 Tabbutt S, Griswold WR, Ogino MT, et al. Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome. J Perinatol 1994;14:66-70.
25. 25 Chowdury V, Lane DA, Mille B, et al. Homozygous antithrombin deficiency: report of two new cases (99Leu to Phe) associated with venous and arterial thrombosis. Thromb Haemostat 1994;72:198-202.
26. 26 Tuddenham EGD, Cooper DN. Protein C and protein C inhibitor. In: Tuddenham EGD, Cooper DN, eds. The molecular genetics of haemostasis and its inherited disorders. New York: Oxford University Press, 1994:148-60.
27. 27 Mahasandana C, Veerakul G, Tanphaichitr VS, et al. Homozygous protein S deficiency: 7 year follow-up. Thromb Haemost 1996;76:1122.
28. 28 Marlar RA, Neumann A. Neonatal purpura fulminans due to homozygous protein C or protein S deficiencies. Semin Thromb Haemost 1990;16:299-310.
29. 29 Millar DS, Allgrove J, Rodeck C, et al. A homozygous deletion/insertion mutation in the protein C (PROC) gene causing neonatal purpura fulminans: prenatal diagnosis in an at risk pregnancy. Blood Coagul Fibrinolysis 1994;5:647-9.
30. 30 Dreyfus M, Masterton M, David M, et al. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Haemost 1995;21:371-81.